Dr. Robert Ward Hagar, MD

Dr. Hagar practices at UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health.

Dr. Hagar's NPI, 1760549182, was assigned on January 3, 2007. Dr. Hagar graduated from UVA School of Medicine in 1983. Dr. Hagar holds California license G53126.

Dr. Hagar's primary practice is UCSF Benioff Children's Hospital Oakland, at 747 52nd Street, Oakland, CA 94609 in Alameda County. The practice phone is (510) 428-3000.

Dr. Hagar's primary practice is UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health. Dr. Hagar is also affiliated with Alta Bates Summit Medical Center. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Hagar to 1 more hospital, 2 medical groups and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hagar practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Hagar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Hagar is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hagar is licensed in California.

Dmand AI lists fibromyalgia and chronic pain among the conditions Dr. Hagar treats.

CMS data shows 278 Medicare services from Dr. Hagar across 3 procedure codes in 2024, for 38 Medicare patients. Medicare paid $20,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Dr. Hagar in 2024. 32% of them have anxiety, and 32% have chronic kidney disease. Their average risk score is 3.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hagar's median patient age at 40, with 50% women.

In 2024, Dr. Hagar wrote 191 Medicare Part D claims for 24 patients. 92% of them were for generic drugs. CMS names the drug for 107 of them, across 6 drugs with 11 or more claims each, at $1,894 in total drug cost. In 2023, CMS named 92 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hagar for performance year 2024, reported as part of a group. Dr. Hagar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hagar as offering telehealth.

Dmand AI links 8 papers to Dr. Hagar, published from 2007 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Anemia, Sickle Cell, Blood Transfusion and Dietary Supplements. Dr. Hagar has published most often in Br J Haematol. Dr. Hagar's most frequent co-authors are Augusta J. Saulys, MD, Elliott P. Vichinsky, MD and Gregory Howard Kurio, MD.

Dmand AI links Dr. Hagar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Anemia, Sickle Cell and Anemia, Hemolytic, Congenital.

CMS Open Payments shows 61 general payments to Dr. Hagar from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Novartis Pharmaceuticals Corporation paid the most, $57,907.

Dr. Hagar graduated from UVA School of Medicine in 1983.

Dr. Hagar is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.